Trial Profile
Evaluation of Recombinant Growth Hormone Therapy to Prevent Muscle Atrophy in Patients With Anterior Cruciate Ligament Tears
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Knee injuries; Muscular atrophy
- Focus Therapeutic Use
- 17 Dec 2019 Status changed from active, no longer recruiting to completed.
- 14 Jul 2019 Planned End Date changed from 1 Dec 2020 to 1 Dec 2019.
- 20 Nov 2018 Planned End Date changed from 1 Dec 2021 to 1 Dec 2020.